Vulva

Primary Site	Histology
C510-C512, C518-C519	8000-8040, 8042-8180, 8191-8246, 8248-8700, 9020, 9071

Notes

8000-8040, 8042-8180, 8191-8246, 8248-8700, 9020, 9071 C510 Labium majus C511 Labium minus C512 Clitoris C518 Overlapping lesion of vulva C519 Vulva, NOS **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 50 *Vulva*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** See the following schemas for the listed histologies * 8041, 8190, 8247: *Merkel Cell Skin* * 8710-8714, 8800-8803, 8810-8921, 8932-8934, 8940-8990, 9000-9016, 9030-9043, 9045-9070, 9072-9138, 9141-9230, 9240-9580, 9582: *Soft Tissue Abdomen and Thoracic* * 8720-8790: *Melanoma Skin* * 8804-8806, 8930-8931, 8991, 9044, 9231, 9581: *Soft Tissue Rare* * 8935-8936: *GIST* * 8992: *Soft Tissue Other* * 9140: *Kaposi Sarcoma* * 9700-9701: *Mycosis Fungoides* **Note 3:** Basal and squamous cell carcinomas of the skin of the vulva are coded to C519 and are reportable; basal and squamous carcinomas of the skin of the perineum would be coded to C445 and would not be reportable.

Data Items
Staging Methods
Outputs

Data Items

Name	Default Value	Used in Derivation	NAACCR Item	Required By	Metadata
Year of Diagnosis		No	NAACCR #390 dateOfDiagnosis		None
Primary Site		Yes	NAACCR #400 primarySite		None
Histology		Yes	NAACCR #522 histologicTypeIcdO3		None
Behavior		Yes	NAACCR #523 behaviorCodeIcdO3		None
Tumor Size Clinical		No	NAACCR #752 tumorSizeClinical		None
Tumor Size Pathological		No	NAACCR #754 tumorSizePathologic		None
Tumor Size Summary	999	Yes	NAACCR #756 tumorSizeSummary		None
Regional Nodes Positive	99	No	NAACCR #820 regionalNodesPositive		None
Regional Nodes Examined	99	No	NAACCR #830 regionalNodesExamined		None
LVI	9	No	NAACCR #1182 lymphVascularInvasion		None
RX Summ Surgery/Radiation Sequence		No	NAACCR #1380 rxSummSurgRadSeq		None
RX Summ Systemic/Surgery Sequence		No	NAACCR #1639 rxSummSystemicSurSeq		None
EOD Primary Tumor	999	Yes	NAACCR #772 eodPrimaryTumor		None
EOD Regional Nodes	999	Yes	NAACCR #774 eodRegionalNodes		None
EOD Mets	00	Yes	NAACCR #776 eodMets		None
SS2018		No	NAACCR #764 summaryStage2018		None
Grade Clinical	9	No	NAACCR #3843 gradeClinical	CCCR/Canada COC NPCR SEER	SSDI
Grade Pathological	9	No	NAACCR #3844 gradePathological	CCCR/Canada COC NPCR SEER	SSDI
Grade Post Therapy Clin (yc)		No	NAACCR #1068 gradePostTherapyClin	COC NPCR SEER	SSDI
Grade Post Therapy Path (yp)		No	NAACCR #3845 gradePostTherapy	CCCR/Canada COC NPCR SEER	SSDI
FIGO Stage	98	No	NAACCR #3836 figoStage	COC SEER	SSDI
LN Status Femoral-Inguinal, Para-aortic, Pelvic	8	No	NAACCR #3884 lnStatusFemorInguinParaaortPelv	None	SSDI 2018–2021
LN Status: Femoral-Inguinal	8	No	NAACCR #3959 lnStatusFemoralInguinal	None	SSDI
Lymph Nodes Assessment Method Femoral-Inguinal	8	No	NAACCR #3871 lnAssessMethodFemoralInguinal	COC SEER (RC)	SSDI
LN Status: Pelvic	8	No	NAACCR #3957 lnStatusPelvic	None	SSDI
Lymph Nodes Assessment Method Pelvic	8	No	NAACCR #3873 lnAssessMethodPelvic	COC SEER (RC)	SSDI
Lymph Nodes Laterality	8	No	NAACCR #3881 lnLaterality	COC SEER	SSDI

Initial Context

Staging Methods

Expand All | Collapse All

Summary Stage 2018

Start

Additional Context

eod_2018_t = 90

eod_2018_m = 90

eod_2018_n = 90

Next Step

EOD Mets
EOD Mets
ss2018_m